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A Review on β-alanine Biosynthesis
Abstract
β-alanine is the only non-proteogenic β-amino acid found in nature and is a precursor for important
molecules biosynthesis in many organisms. Speci cally, it is a precursor for pantothenate in
microorganisms, and a component of the dipeptides anserine and carnosine in mammals.
Furthermore, β-alanine plays a role in insect exoskeleton formation and is part of plant environmental
stress response. Apart from its natural role in organisms, β-alanine has applications in nutrition,
pharmaceuticals, chemical synthesis, and construction  elds. Due to its health-promoting bene t,
β-alanine is increasingly being used by athletes to augment exercise performance and endurance.
Moreover, it is a precursor for the synthesis of pamidronate sodium, balsalazide, and other drugs in the
pharmaceutical industry. Additionally, β-alanine has been proposed as an intermediate to industrially
relevant nitrogen-containing compounds. Traditionally, β-alanine has been produced through harsh
chemical synthesis routes which often yield unwanted by-products. Recently, β-alanine production is
moving towards relatively environmental- friendly whole-cell biosynthesis providing an attractive
alternative that enables enantiomerically pure compound production. Some bio-based methods,
however, are limited by enzyme inhibition, low stoichiometric yield, and expensive production cost.
Hence, the purpose of this work is to review the recent signi cant attempts at addressing the
limitations of β-alanine production.
Introduction
β-alanine is the only β-amino acid produced in nature. It does not partake in protein synthesis but is a
precursor for many essential molecules in organisms. For example, β-alanine is a precursor to
pantothenate in microorganisms, a component of the intracellular pH bu er carnosine in mammals, a
part of exoskelaton formation in insects (Wang et al., 2021), and a component of  stress response in
plants (Pei et al., 2017). Because it is the limiting reactant in carnosine synthesis, β-alanine is
increasingly being used as a sports supplement to augment performance and recovery in athletes (Lily
and Papandreou, 2014). In addition to its value as a sports supplement, β-alanine is gaining popularity
as a precursor molecule to industrially-relevant nitrogen-containing compounds such as acrylamide,
acrylonitrile, and poly-β-alanine (nylon-3) (Steunenberg et al., 2013). Conventional chemical routes
for β-alanine synthesis utilize harsh conditions and produce undesired by-products (Song et al., 2015),
necessitating more environmentally-friendly and e cient β-alanine synthesis methods. Greener
β-alanine production methods such as enzymatic approaches entail converting L-aspartate to β-alanine
using puri ed L-aspartate-alpha-decarboxylase (ADC) (Wang et al., 2021). However, the cost of
enzyme extraction and puri cation as well as ADC’s instability and tendency for mechanism-based
inhibition make enzymatic approaches less attractive (Song et al., 2015). Recently, whole-cell
biocatalytic approaches for β-alanine synthesis have been proposed due to the elimination of enzyme
processing costs and ADC’s increased stability in cells (Li et al., 2018). To further optimize whole-cell
approaches, ADC must be engineered to increase its resistance to mechanism-based inhibition.
Additionally, a suite of intracellular components, such as co-factor balancing and gene interactions
must be addressed in order to optimize whole-cell ADC biosynthesis.
Metabolic role of  β-alanine
In E. coli, β-alanine and D-pantoic acid are precursors for D-pantothenate (vitamin B5), a precursor for
coenzyme A which plays a vital role in lipid synthesis (Cronan 1980). In humans and other mammals,
β-alanine is a component in both the dipeptides anserine and carnosine, which are abundantly found
in skeletal muscle (Williamson and Brown 1979). In insects, β-alanine plays a role in exoskeleton
development (Fukushi 1967), and in plants, it is involved in stress response (Pei et al., 2017).
β-alanine synthesis in microorganisms
In E. coli, β-alanine is synthesized primarily through the alpha-decarboxylation of L-aspartate
by L-aspartate-alpha-decarboxylase (ADC or PanD) encoded by the panD gene (Williamson
and Brown, 1979; Cronan 1980). β-alanine can also be yielded from uracil degradation;
however, this is a minor pathway for β-alanine production in microorganisms (Cronan 1980).
In microorganisms, pantothenate production is preceded by the alpha-decarboxylation
pathway for β-alanine synthesis. Pantothenate is synthesized from the condensation of pantoic
acid and β-alanine, of which β-alanine is the rate-limiting reactant (Cronan, 1980).
Pantothenate is then enzymatically modi ed into coenzyme A, its metabolically active form
(Williamson and Brown, 1979). Therefore, the formation of β-alanine from the
alpha-decarboxylation of L-aspartate is an integral part in the formation of coenzyme A in
microbes (Williamson and Brown, 1979).
ADC synthesizes β-alanine from L-aspartate
ADC is encoded by the gene panD. ADCs can be classi ed into a bacterial and insect
subtype which di er mainly by their cofactor dependence (Wang et al., 2020).
Speci cally, bacterial ADC utilized by E. coli, Mycobacterium tuberculosis, and Bacillus
subtilis is dependent on a pyruvoyl group as a cofactor (Wang et al., 2020). Bacterial
ADC is  rst translated as an inactive pro-protein, which is proteolytically cleaved at the
Gly24-Ser25 site to produce the mature, catalytically active form of ADC. Mature
ADC consists of an 11 kDa alpha-subunit containing a pyruvoyl group and a 3 kDa
β-subunit (Pei et al., 2017, Ramjee et al., 1997). The ADC pro-protein can be cleaved
by a separate protein PanZ/PanM or undergo self-cleavage. Stuecker et al. (2015)
report two classes of pyruvoyl-dependent ADCs: one that must be cleaved by an
activator (i.e. PanZ/PanM) and another that can undergo self-cleavage. However, upon
analysis of 33 di erent pyruvoyl-dependent ADCs, Mo et al. (2018) propose a third
class of pyruvoyl-dependent ADC with an intermediate ability to self-cleave. Under the
scheme proposed by Mo et al. (2018), Class I pyruvoyl-dependent ADCs require an
activator such as PanZ/PanM to cleave the ADC pro-protein, Class II
pyuvoyl-dependent ADCs can partially self-cleave, while Class III pyruvoyl-dependent
ADCs can completely self-cleave and do not require an activator. For example, E. coli
ADC relies on PanZ/PanM for cleavage (Pei et al., 2017), L. plantarum ADC can only
partially self-cleave (Zhang et al. 2018), while B. subtilis and Corynebacterium
glutamicum ADCs can fully self-cleave (Pei et al. 2017),
Bacterial ADCs belongs to a larger group of pyruvoyl-dependent enzymes, including
gram positive histidine decarboxylases (characterized and discovered in Lactobacillus
30a (Williamson and Brown, 1979)), E. coli phosphatidylserine decarboxylase,
Colistridia spp. proline reductase (Anton and Kutny, 1987, Williamson and Brown,
1979), E. coli, yeast, and rat liver S-adenosylmethionine decarboxylase, E. coli
phosphatidylserine decarboxylase. Pyruvoyl-dependent enzymes inherently exhibit
mechanism-based inactivation, which results in irreversible inactivation of the enzyme
(Anton and Kutny 1987). Thus, ADC’s tendency for mechanism-based inactivation
stands as an obstacle to its e cient application in commercial β-alanine synthesis.
Pyridoxal-5’-Phosphate (PLP)-dependent ADCs are found mainly in eukaryotes such
as plants and insects (Yu et al., 2020). One example, the insect ADC found in the red
 our beetle, Tribolium castaneum, is responsible for providing β-alanine for insect
epidermal tanning (Wang et al., 2020). As opposed to pyruvoyl-dependent bacterial
ADCs, insect ADC is dependent on pyridoxal-5′-phosphate as a cofactor (Wang et al.,
2020). Therefore, insect ADCs are not subject to the same mechanism-based
inactivation inherent to bacterial ADCs (Wang et al., 2020). This makes insect ADC
an attractive candidate for commercial β-alanine synthesis from L-aspartate.
Metabolic role of  β-alanine in mammals
In humans, β-alanine is obtained by the degradation of uracil in the liver and from β-alanine
containing-peptides from meats (Lily and Papandreou, 2014). One of β-alanine’s main functions in
humans is as a precursor molecule to the dipeptide carnosine. Carnosine is a dipeptide formed by the
condensation of L-histidine and β-alanine catalyzed by carnosine synthase. Carnosine synthase activity
is high in skeletal muscle regions of the brain such as the olfactory bulb, indicating its locations of
highest concentration. In skeletal muscles, the imidazole group in the histidine component of
carnosine acts as an intracellular cytoplasmic bu er (Lily and Papandreou, 2014). Of the two carnosine
precursors, β-alanine is the rate-limiting reactant in carnosine synthesis; therefore, the regulation of
intracellular pH in muscle cells is limited by β-alanine concentration. In the blood, serum carnosinase
enzymatically hydrolyzes carnosine into its subcomponents, so carnosine is undetectable in the
blood(Lily and Papandreou, 2013). Since β-alanine is the rate-limiting reactant in carnosine synthesis,
β-alanine supplementation increases intramuscular carnosine concentration. An increase in
intramuscular carnosine concentration improves athletic performance and endurance due to the better
regulated intracellular pH.
Industrial applications of  β-alanine
Due to its role in intracellular pH regulation, particularly during periods of high activity, β-alanine has
been used as a supplement to increase endurance in athletes. Additionally, β-alanine has been proposed
as an intermediate to industrially-relevant nitrogen-containing compounds such as acrylamide and
acrylonitrile (Konst et al., 2009). For example, Konst et al. (2009) proposes the conversion of
cyanobacterial and yeast cyanophycin-rich biomass grown from agricultural and industrial waste to
β-alanine as an intermediate to valuable nitrogen-containing compounds. β-alanine can also be used as
a direct precursor to Nylon-3 (poly-β-alanine), which has applications in cosmetics, water puri cation,
and construction (Steunenberg 2013). The traditional method for Nylon-3 synthesis uses acyrlamide
as a precursor but produces unwanted branched byproducts. The β-alanine-based method for Nylon-3
production is instead more e cient but requires a reliable and cost-e cient source of β-alanine. (Song
et al., 2015).
Industrial production of  β-alanine
Traditionally, β-alanine has been produced through chemical methods, including reacting acrylonitrile
with ammonia, introducing β-aminopropionitrile to barium hydroxide in harsh conditions, and
reacting acrylic acid with ammonium carbonates and carbon dioxide (Song et al., 2015). These
chemical approaches use harsh reactants and produce unwanted by-products, necessitating the
development of more environmentally-friendly and e cient methods. More recently, β-alanine has
been produced through whole-cell enzymatic systems. Some proposed biological pathways include the
conversion of β-aminopropionitrile or aspartic acid to β-alanine in whole-cell systems. For example,
Song et al. (2015) developed a novel strategy for producing β-alanine in E. coli, in which C. glutamicum
L-asparatate-alpha-decarboxylase (PanD), aspartase (AspA), and phosphoenolpyruvate carboxylase
(PPC) genes were overexpressed in E. coli W3110.
β-alanine synthesis engineering
β-alanine can be synthesized using ADC and L-aspartate as a substrate. Enzymatic conversion of
β-alanine from L-aspartate is more environmentally friendly than the conventional chemical methods.
However, the enzymatic production pathway is limited by ADC mechanism-based inhibition and the
high cost of protein extraction and puri cation. Conversion of L-aspartate to β-alanine through a
whole-cell approach is a better alternative to chemical and enzymatic methods since ADC is more
stable and shows higher activity in vivo (Li et al., 2018)
ADC across organisms
Two subtypes of ADC are present in organisms: the pyruvoyl-dependent ADC in prokaryotes,
speci cally bacteria, and the PLP-dependent ADC in insects and plants. The majority of
studies and genetic engineering on ADC has been focused on the bacterial pyuvate-dependent
ADC. Pei et al. (2017) studied bacterial ADCs from E. coli, C. glutamicum, B. subtilis and
concluded the B. subtilis ADC is the best suited for industrial application. B. subtilis ADC was
more resistant against mechanism-based inactivation, more thermostable, and exhibited higher
speci c activity than ADCs from E. coli and C. glutamicum (Pei et al., 2017). Additionally,
Zhang et al. (2018) demonstrated that B. subtilis ADC was more active and stable when
compared to C. glutamicum and L. plantarum ADCs. B. subtilis ADC was also able to
self-cleave whereas other forms of ADCs (e.g. E. coli ADC) require a separate activator,
PanZ/PanM, to cleave the ADC pro-protein (Pei et al., 2017). Taken together, B. subtilis
ADC’s ability to self-cleave is advantageous for industrial applications since less gene
components need to be engineered into the host for ADC maturation, thereby reducing the
metabolic burden on the host.
Due to the inherent mechanism-based inactivation of pyurvoyl-dependent ADCs, more
studies have been conducted on insect PLP-dependent ADC to avoid the mechanism-based
inactivation. Unlike pyruvoyl-dependent enzymes, PLP-dependent ADC does not need to be
cleaved to mature, making it an attractive alternative to pruvoyl-dependent ADCs. Yu et al.
(2020) genetically engineered Tribolium castaneum ADC (TcADC) for industrial β-alanine
production. Using random mutagenesis and site-directed saturation mutagenesis, they created
a TcADC mutant, (TcPanD-R98H/K305S) that exhibited 2.45 times higher enzymatic
activity than the wild type TcADC. Through analysis of their TcPanD-R98H/K305S mutant,
Yu et al. (2020) propose that the R98H mutation stabilizes the enzyme while the K305S
mutation strengthens enzyme-substrate binding. These mutations may serve as a foundation
for future optimization of insect ADC. Nevertheless, the majority of protein engineering
e orts (e.g. random and/or site-directed mutagenesis) for β-alanine synthesis has been focused
on bacterial pyruvoyl-dependent ADC.
Mechanism-based inactivation of  pyruvoyl-dependentADC
Mechanism-based inactivation of ADC stands in the way of ADC’s industrial application.
ADC belongs to a group of enzymes called pyruvoyl-dependent enzymes (Mo et al. 2018, Van
and Snell 1990) and experiences mechanism-based inactivation common to this group of
enzymes (Pei et al., 2017). S-adenosylmethionine decarboxylase is an extensively studied
enzyme that belongs to this group. Studies on S-adenosylmethionine decarboxylase show the
mechanism of inactivation for pyruvoyl-dependent enzymes:
A schi  base is formed between the substrate and the pyrovoyl group of the enzyme. The
imininium intermediate may be protonated on the substrate or the enzyme, leading to the
amination of either the substrate or enzyme. Amination of the substrate leads to production of
β-alanine, catalytically regenerating the active enzyme, while amination of the pyruvoyl group
leads to the irreversible inactivation of the enzyme. (Pei et al., 2017, Anton and Kutny 1987,
Lee and Suh 2004).
Preventing inactivation
The two competing protonation pathways determine whether ADC is inactivated or
regenerated for catalysis. Therefore, favoring the desired protonation pathway - the
protonation of the substrate over the pyruvoyl group - may prevent the inactivation of
ADC (Pei et al., 2017). Pei et al. (2017) randomly mutated sequences of the B. subtilis
ADC and screened for higher enzymatic activity and catalytic stability in ADC
variants. From 4000 variants, they found two variants which exhibited 18–22% higher
enzymatic activity and 29–64% higher catalytic stability than wild type ADC.
Analyzing their ADC variants, Pei et al. (2017) found that mutations in the
C-terminus, speci cally L127, the last amino acid in B. subtilis ADC increased its
catalytic stability. Additionally, amino acid sequence alignments between 16 ADC
genes showed the most variation in ADC’s C-terminus loop (Pei et al., 2017, Lee and
Suh 2004). These  ndings suggest future engineering of this location may improve
ADC’s resistance to mechanism-based inactivation. Indeed, Qian et al. (2020)
demonstrated a C-terminal deletion in B. subtilis ADC favored the desired protonation
pathway.
Zhang et al. (2018) performed site-directed mutagenesis on B. subtilis ADC and found
their Glu56Ser ADC mutant exhibited 1.6-fold higher catalytic activity, increased
thermostability, and decreased mechanism-based inactivation. Their Glu56Ser B.
subtilis ADC mutant was heterologously expressed in E. coli BL21 which produced
215.3 g/L β-alanine, the highest β-alanine biosynthesis yield reported so far.
Qian et al. (2020) propose two factors a ect the mechanism-based inactivation of
pyruvoyl-dependent ADCs. A short distance between the proton donor Tyr58 and the
pyruvoyl group results in a higher likelihood of the protonation of the enzyme, leading
to the irreversible inactivation of the enzyme. The remedy for this problem is
increasing the protonation distance between the proton donor and the pyruvoyl group
- doing so will increase the energy barrier needed to protonate the enzyme, thereby
increasing the likelihood that the correct protonation pathway is followed. Second, the
structural  exibility of ADC may a ect which protonation pathway occurs. Excessive
 exibility of ADC fosters the incorrect enzyme con guration for protonation of the
substrate. Rather, a more stable con guration may favor the desired protonation
pathway. Through site-directed saturation mutation and c-terminus deletion, Qian et
al. produced a B. subtilis ADC mutant that remedies both of these problems; their
mutant ADC Q5 exhibited a 3.48-times higher half-life and a 2.52 times higher total
turnover number.
Whole-cell approaches
Li et al. (2018) employ a whole-cell catalytic approach using C. glutamicum ADC expressed in E. coli
BL21 (BL21(DE3)/pET28a-panDC)yielding 24.8 g/L β-alanine from 40 g/L L-aspartate (92.6%
yield). Their whole-cell approach showed higher β-alanine production than that of the crude extracts.
Although the cell membrane limits import of starting material and export of accumulated product. Li
et al. (2018) propose that their whole-cell approach produces more β-alanine because the cell
membrane prevents L-aspartate substrate inhibition of ADC that occurs when producing β-alanine
with crude extract.
Wang et al. (2020) employ a novel two-enzyme whole-cell system to convert L-aspartate to β-alanine.
Wang et al. rely on B. subtilis ADC and T. castaneum ADC, which represent the two subtypes of the
ADC enzyme - B. subtilis ADC relies on a pyruvoyl group as a cofactor while T. castaneum ADC relies
on pyridoxal-5′-phosphate as a cofactor. This study co-expressed B. subtilis ADC and T. castaneum
ADC in E. coli and displayed a 92.4% conversion rate from L-aspartate to β-alanine. Additionally,
Wang et al. (2020) developed a “one-pot” three-enzyme system to convert fumaric acid to β-alanine.
Starting with fumaric acid, Wang et al. use E. coli aspartase-catalyzed ammonization to convert fumaric
acid to L-asparte and B. subtilis ADC and T. castaneum ADC to convert L-aspartate to β alanine. Their
one-pot method yielded a 90% conversion rate from fumaric acid to β-alanine.
De novo synthesis of  β-alanine
Some whole-cell methods have employed a fed-batch approach to produce β-alanine from
L-aspartate or fumarate. Other β-alanine production engineering focuses instead on
synthesizing β-alanine de novo from glucose. For example, Song et al. (2015) achieved a yield of
0.135 g β-alanine/g glucose at a productivity of 0.828 g/L/h by overexpressing
Corynebacterium glutamicum ADC, native asparatase, and phosphoenolpyruvate carboxylase.
Similarly, Piao et al. (2019) increased their β-alanine yield from glucose by optimizing
L-aspartate production, speci cally increasing L-aspartate aminotransferase and ADC
expression in E. coli.
TCA pathways for de novo β-alanine synthesis
Increasing the supply of L-aspartate, the direct precursor of β-alanine, should improve the
theoretical yield of β-alanine in a whole-cell system. L-aspartate can be produced from
fumarate or oxaloacetate through a number of pathways. Speci cally, phosphoenolpyruvate
(PEP) is converted to fumarate, an L-aspartate precursor, through the oxidative branch of the
TCA cycle. This pathway synthesizes L-aspartate - and subsequently β-alanine - at a theoretical
yield of 1 mol β-alanine/mol glucose (Piao et al. 2019). 1.33 mol L-aspartate/mol glucose can
theoretically be synthesized from supplementing the oxidative branch of the TCA cycle with
the glyoxylate cycle, which replenishes TCA cycle intermediates (Piao et al. 2019). Song et al.
(2015) were the  rst to develop de novo synthesis of β-alanine from glucose by augmenting
L-aspartate synthesis via the oxidative arm of the TCA cycle. By replacing the native promoter
for aspA, an aspartate ammonia-lyase-encoding gene, with the strong trc promoter, they were
able to increase fumarate conversion to L-aspartate. Additional expression of Corynebacterium
glutamicum ADC and ppc, a phosphoenolpyruvate carboxylase-encoding gene, increased their
engineered strain’s β-alanine productivity to 0.828 g/L/h. This yield is relatively low due to the
loss of CO2 through the oxidative branch of the TCA cycle.
Conversely, Piao et al. (2019) proposes the most e cient L-aspartate synthesis pathway is the
reductive branch of the TCA cycle, which generates oxaloacetate from PEP. This pathway has
the highest L-aspartate theoretical yield at 2 mol L-aspartate/mol glucose. The reductive branch
of the TCA cycle conserves carbon, whereas the oxidative TCA pathway and glyoxylate cycle
lose carbon through CO2. The reductive TCA branch is the shortest pathway from PEP to
L-aspartate; therefore, utilizing it for β-alanine synthesis may bypass complicated regulation
associated with other pathways (Piao et al. 2019). Piao et al. (2019) overexpressed C.
glutamicum ppc to increase the conversion of PEP to oxaloacetate and Bacillus subtilis ADC to
drive metabolic  ux to L-aspartate and β-alanine synthesis pathways. Further, to reduce
competitive oxaloacetate- and L-aspartate-consuming pathways, Piao et al. deleted mdh, a
malate dehydrogenase-encoding gene, and aspA (aspartate ammonia-lyase catalyzes the
reversible conversion between fumarate and L-aspartate (Piao et al. 2019)). With these genetic
modi cations, their highest β-alanine yield was 1.52 mol β-alanine/mol glucose, equivalent to
76% of the theoretical yield.
Some alternative methods for biosynthesizing β-alanine include extracellularly expressing ADC for
β-alanine conversion from L-aspartate. To do this, Feng et al. (2019) expressed a Bacillus tequilensis
ADC tagged with signal peptides for transmembrane export. Additionally, they co-expresssed the
ADC with T. fusca cutinase, which catalyzes phospholipid hydrolysis, to increase non-speci c release
of intracellular proteins. The export of overexpressed ADC relieves the cell of the metabolic burden
caused by exogenous protein accumulation in the cell, theoretically increasing the productivity of the
cell. To prevent the substrate inhibition of ADC by L-aspartate at high concentrations, Feng et al.
(2019) utilized a continuous L-aspartate feeding regimen. With their novel approach, Feng et al.
demonstrated extracellular expression of ADC exhibited 1.4-fold improvement in β-alanine
production than intracellular ADC expression.
Perspective
The majority of the work on augmenting β-alanine biosynthesis has been concentrated on optimizing
L-aspartate conversion to β-alanine by pyruvoyl-dependent ADCs. Pyruvoyl-dependent ADCs are
more well-studied and more prevalent in microorganisms. However, they are limited by
mechanism-based inhibition and the need for activation by cleavage; thus, they require continued
improvement through protein engineering. There have been comparatively less studies on
PLP-dependent ADCs, which do not exhibit substrate inhibition and do not need to be cleaved to
fully mature. PLP-dependent ADC may be a promising enzyme for β-alanine biosynthesis but has not
been widely used for this purpose. Strategies to improve both subtypes of ADCs have mainly been
random mutagenesis and site-directed saturation mutagenesis, which continue to be the most e cient
methods for protein optimization. To date, the highest β-alanine yield was obtained by Zhang et al.
(2018) who optimized a B. subtilis pyruvoyl-dependent ADC through site-directed mutagenesis.
Moving forward, continued protein engineering of pyurvoyl-dependent ADCs and synthesis of
β-alanine through a whole-cell, de novo approach may result in the most cost-e cient and highest
β-alanine yield.
Works Cited
Anton, D. L., & Kutny, R. (1987). Mechanism of substrate inactivation of Escherichia coli
S-adenosylmethionine decarboxylase. Biochemistry, 26(20), 6444-6447.
Cronan, J. E. (1980). Beta-alanine synthesis in Escherichia coli. Journal of Bacteriology, 141(3),
1291-1297.
Feng, Z., Zhang, J., Chen, G., Ge, Y., Zhang, X., & Zhu, H. (2019). Extracellular Expression of
L-Aspartate-α-Decarboxylase from Bacillus tequilensis and Its Application in the Biosynthesis
of β-Alanine. Applied biochemistry and biotechnology, 189(1), 273-283.
Könst, P. M., Franssen, M. C., Scott, E. L., & Sanders, J. P. (2009). A study on the applicability of
L-aspartate α-decarboxylase in the biobased production of nitrogen containing chemicals.
Green Chemistry, 11(10), 1646-1652.
Lee, B. I., & Suh, S. W. (2004). Crystal structure of the schi  base intermediate prior to
decarboxylation in the catalytic cycle of aspartate α-decarboxylase. Journal of molecular biology,
340(1), 1-7.
Li, H., Lu, X., Chen, K., Yang, J., Zhang, A., Wang, X., & Ouyang, P. (2018). β-alanine production
using whole-cell biocatalysts in recombinant Escherichia coli. Molecular Catalysis, 449, 93-98.
Lily, E., & Papandreou, D. (2014). The role and e ects of carnosine and β-alanine on exercise: an
updated mini review. Nutrition & Food Science.
Mo, Q., Li, Y., Wang, J., & Shi, G. (2018). Identi cation of mutations restricting autocatalytic
activation of bacterial l-aspartate α-decarboxylase. Amino acids, 50(10), 1433-1440.
Mo, Q., Mao, A., Li, Y., & Shi, G. (2019). Substrate inactivation of bacterial L-aspartate
α-decarboxylase from Corynebacterium jeikeium K411 and improvement of molecular
stability by saturation mutagenesis. World Journal of Microbiology and Biotechnology, 35(4),
1-8.
Pei, W., Zhang, J., Deng, S., Tigu, F., Li, Y., Li, Q., ... & Li, Y. (2017). Molecular engineering of
L-aspartate-α-decarboxylase for improved activity and catalytic stability. Applied microbiology
and biotechnology, 101(15), 6015-6021.
Piao, X., Wang, L., Lin, B., Chen, H., Liu, W., & Tao, Y. (2019). Metabolic engineering of Escherichia
coli for production of L-aspartate and its derivative β-alanine with high stoichiometric yield.
Metabolic engineering, 54, 244-254.
Qian, Y., Lu, C., Liu, J., Song, W., Chen, X., Luo, Q., ... & Wu, J. (2020). Engineering protonation
conformation of l‐aspartate‐α‐decarboxylase to relieve mechanism‐based inactivation.
Biotechnology and bioengineering, 117(6), 1607-1614.
Song, C. W., Lee, J., Ko, Y. S., & Lee, S. Y. (2015). Metabolic engineering of Escherichia coli for the
production of 3-aminopropionic acid. Metabolic engineering, 30, 121-129.
Steunenberg, P., Könst, P. M., Scott, E. L., Franssen, M. C., Zuilhof, H., & Sanders, J. P. (2013).
Polymerisation of β-alanine through catalytic ester–amide exchange. European polymer
journal, 49(7), 1773-1781.
Wang, L., Piao, X., Cui, S., Hu, M., & Tao, Y. (2020). Enhanced production of β-alanine through
co-expressing two di erent subtypes of l-aspartate-α-decarboxylase. Journal of Industrial
Microbiology and Biotechnology, 47(6-7), 465-474.
Williamson, J. M., & Brown, G. M. (1979). Puri cation and properties of
L-Aspartate-alpha-decarboxylase, an enzyme that catalyzes the formation of beta-alanine in
Escherichia coli. Journal of Biological Chemistry, 254(16), 8074-8082.
Yu, X. J., Huang, C. Y., Xu, X. D., Chen, H., Liang, M. J., Xu, Z. X., ... & Wang, Z. (2020). Protein
engineering of a pyridoxal-5′-phosphate-dependent l-aspartate-α-decarboxylase from Tribolium
castaneum for β-alanine production. Molecules, 25(6), 1280.
Zhang, T., Zhang, R., Xu, M., Zhang, X., Yang, T., Liu, F., ... & Rao, Z. (2018). Glu56Ser mutation
improves the enzymatic activity and catalytic stability of Bacillus subtilis L-aspartate
α-decarboxylase for an e cient β-alanine production. Process biochemistry, 70, 117-123.
